These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 1361410
21. Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo. Finnegan KT, Taraska T. J Neurochem; 1996 May; 66(5):1949-58. PubMed ID: 8780022 [Abstract] [Full Text] [Related]
22. MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity. Gibb JW, Johnson M, Hanson GR. NIDA Res Monogr; 1989 May; 95():511. PubMed ID: 2577049 [No Abstract] [Full Text] [Related]
23. Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats. Champney TH, Matthews RT. J Pineal Res; 1991 May; 11(3-4):163-7. PubMed ID: 1724461 [Abstract] [Full Text] [Related]
38. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study. Pu C, Vorhees CV. Synapse; 1995 Feb 22; 19(2):97-104. PubMed ID: 7725247 [Abstract] [Full Text] [Related]
39. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Nash JF. Life Sci; 1990 Feb 22; 47(26):2401-8. PubMed ID: 1979830 [Abstract] [Full Text] [Related]
40. MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Muraki A, Koyama T, Nakayama M, Ohmori T, Yamashita I. Neurosci Lett; 1992 Feb 17; 136(1):39-42. PubMed ID: 1353257 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]